Biblio Discovery — Demo Discovery Service

4 results for "Baoding Zhang"

Showing 1–4 · 0.62 seconds · RSS

  1. Journal Article

    Inhibiting NEDD4 in triple-negative breast cancer cells reprograms tumor immune microenvironment via the β-TrCP/YAP/ECM axis

    Nan Su; Wenhua Lian; Baoding Zhang et al.

    Cell Reports Medicine, Vol. 6 No. 10 · 2025 · English · DOAJ Scopus

    Summary: Tumor immune microenvironment greatly influences triple-negative breast cancer (TNBC) progression. Identifying targets to convert “cold” tumors into “hot” tumors holds promise for improving treatment outcomes. Here, we show that high expression of NEDD4, an HECT-type E3 ubiquitin ligase…

  2. Journal Article

    METTL10‐Mediated PIAS3 Methylation Links Purine Metabolism to Gastric Cancer Progression

    Jinshui Tan; Huiwen Zhou; Jingsong Ma et al.

    Advanced Science, Vol. 12 No. 48 · 2025 · English · DOAJ Scopus

    Abstract Metabolic dysregulation plays a significant role in the development of gastric cancer (GC). However, the mechanisms that control this change and its impact on GC progression remain poorly understood. In this study, it is demonstrated that methyltransferase‐like 10 (METTL10) is a key…

  3. Journal Article

    A new ALK inhibitor overcomes resistance to first‐ and second‐generation inhibitors in NSCLC

    Yue Lu; Zhenzhen Fan; Su‐Jie Zhu et al.

    EMBO Molecular Medicine, Vol. 14 No. 1 · 2021 · English · DOAJ Scopus

    Abstract More than 60% of nonsmall cell lung cancer (NSCLC) patients show a positive response to the first ALK inhibitor, crizotinib, which has been used as the standard treatment for newly diagnosed patients with ALK rearrangement. However, most patients inevitably develop crizotinib resistance…